IPO Market Update for the Life Sciences Industry

Webcast overview

In this webcast professionals from KPMG, J.P. Morgan, and Nasdaq provide their insights and perspectives on the IPO market for the life sciences industry.

Topics discussed on this webcast include:

  • Capital markets update for the life sciences industry

  • Impact of COVID-19 on the life sciences ecosystem

  • IPO market dynamics: potential “IPO windows” for the balance of 2020, the virtual IPO roadshow, and investor risk tolerance for new issuance

  • Guidance for leaders at both late-stage life sciences companies (who hope to IPO in 2020) and early-stage life sciences companies (who are interested in an IPO down the road)

View the replay

Featured speakers

Janet Lehman

Janet Lehman

Partner, Audit, U.S. Venture Capital Life Sciences Leader, KPMG US

David Ke

David Ke

Executive Director, Equity Capital Markets, Investment Banking, J.P. Morgan

Jordan Saxe

Jordan Saxe

Senior Managing Director, Head of Healthcare, Capital Markets, Nasdaq